Medical oncologist Dr. Komal Jhaveri presented results from a clinical trial testing a drug known as an antibody-drug conjugate, which delivers a chemotherapy payload more precisely to breast cancer ...
Septerna, Inc. aims to raise $100 million in an IPO to advance its clinical-stage biopharma treatments for endocrine diseases, with SEP-786 in Phase 1 trials. The hypoparathyroidism treatment market ...
When these hormones become imbalanced, it can lead to the development of an endocrine disorder. “An endocrine disorder occurs when your body produces either too much or too little of a particular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback